This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fan, W. Articles by Huang, T. Search for Related Content PubMed PubMed Citation Articles by Fan, W. Articles by Huang, T.

TBX3 and Its Isoform TBX3+2a Are Functionally Distinctive in Inhibition of Senescence and Are Overexpressed in a Subset of Breast Cancer Cell Lines

¹ Division of Genetics, Department of Pediatrics, University of California, Irvine, California; ² Laboratory Medicine and Radiation Oncology, Cancer Genetics and Breast Oncology, UCSF Comprehensive Cancer Center, University of San Francisco, San Francisco, California; and ³ Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California

TBX3 is a transcription factor of the T-box gene family. Mutations of TBX3 cause ulnar-mammary syndrome (MIM 181450) in humans, an autosomal dominant disorder characterized by the absence or underdevelopment of the mammary glands and other congenital anomalies. It recently was found that TBX3 was able to immortalize mouse embryo fibroblast (MEF) cells. In addition, TBX2, a homologue of TBX3, is active in preventing senescence in rodent cells and was found to be amplified in some human breast cancers, suggesting TBX3 plays a role in breast cancer. This study examined the function of TBX3 and its isoform, TBX3 + 2a. TBX3 + 2a differs from TBX3 in the DNA binding domain with an extra 20 amino acids produced by alternative splicing. We first examined the tissue expression and alternative splicing patterns of these two isoforms. We found that TBX3 and TBX3 + 2a are widely expressed in humans and mice, and alternative splicing could be tissue specific and species specific. Overexpression of TBX3 is able to immortalize MEF cells, whereas TBX3 + 2a shows an acceleration of senescence, a functional difference that may be explained by the fact that these two isoforms may have different downstream targets. TBX3, but not TBX3 + 2a, is able to bind to the previously identified T-box binding site in a gel shift assay. A subset of human breast cancer cell lines overexpresses TBX3. Our results indicate that TBX3 and TBX3 + 2a are functionally distinctive in inhibition of senescence of MEF cells and may play a role in breast cancer.

This article has been cited by other articles:

				M. A. Patil, S. A. Lee, E. Macias, E. T. Lam, C. Xu, K. D. Jones, C. Ho, M. Rodriguez-Puebla, and X. Chen Role of Cyclin D1 as a Mediator of c-Met- and {beta}-Catenin-Induced Hepatocarcinogenesis Cancer Res., January 1, 2009; 69(1): 253 - 261. [Abstract] [Full Text] [PDF]

				M. Rodriguez, E. Aladowicz, L. Lanfrancone, and C. R. Goding Tbx3 Represses E-Cadherin Expression and Enhances Melanoma Invasiveness Cancer Res., October 1, 2008; 68(19): 7872 - 7881. [Abstract] [Full Text] [PDF]

				R. Georges, G. Nemer, M. Morin, C. Lefebvre, and M. Nemer Distinct Expression and Function of Alternatively Spliced Tbx5 Isoforms in Cell Growth and Differentiation Mol. Cell. Biol., June 15, 2008; 28(12): 4052 - 4067. [Abstract] [Full Text] [PDF]

				R. R Copley The animal in the genome: comparative genomics and evolution Phil Trans R Soc B, April 27, 2008; 363(1496): 1453 - 1461. [Abstract] [Full Text] [PDF]

				W. Yarosh, T. Barrientos, T. Esmailpour, L. Lin, P. M. Carpenter, K. Osann, H. Anton-Culver, and T. Huang TBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases Cancer Res., February 1, 2008; 68(3): 693 - 699. [Abstract] [Full Text] [PDF]

				A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince UV-mediated Regulation of the Anti-senescence Factor Tbx2 J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230. [Abstract] [Full Text] [PDF]

				C. Palena, D. E. Polev, K. Y. Tsang, R. I. Fernando, M. Litzinger, L. L. Krukovskaya, A. V. Baranova, A. P. Kozlov, and J. Schlom The Human T-Box Mesodermal Transcription Factor Brachyury Is a Candidate Target for T-Cell-Mediated Cancer Immunotherapy Clin. Cancer Res., April 15, 2007; 13(8): 2471 - 2478. [Abstract] [Full Text] [PDF]

				C.-A. Renard, C. Labalette, C. Armengol, D. Cougot, Y. Wei, S. Cairo, P. Pineau, C. Neuveut, A. de Reynies, A. Dejean, et al. Tbx3 Is a Downstream Target of the Wnt/{beta}-Catenin Pathway and a Critical Mediator of {beta}-Catenin Survival Functions in Liver Cancer Cancer Res., February 1, 2007; 67(3): 901 - 910. [Abstract] [Full Text] [PDF]

				M. Guray and A. A. Sahin Benign breast diseases: classification, diagnosis, and management. Oncologist, May 1, 2006; 11(5): 435 - 449. [Abstract] [Full Text] [PDF]

				C.-L. Cai, W. Zhou, L. Yang, L. Bu, Y. Qyang, X. Zhang, X. Li, M. G. Rosenfeld, J. Chen, and S. Evans T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis Development, May 15, 2005; 132(10): 2475 - 2487. [Abstract] [Full Text] [PDF]

				L. Zhao, T. Tong, and Z. Zhang Expression of the Leo1-like domain of replicative senescence down-regulated Leo1-like (RDL) protein promotes senescence of 2BS fibroblasts FASEB J, April 1, 2005; 19(6): 521 - 532. [Abstract] [Full Text] [PDF]

				K. W. Vance, S. Carreira, G. Brosch, and C. R. Goding Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas Cancer Res., March 15, 2005; 65(6): 2260 - 2268. [Abstract] [Full Text] [PDF]